Ptc Therapeutics reported $-84730000 in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Bluebird Bio BLUE:US $ -135.67M 81.29M
Cytokinetics CYTK:US $ -80.55M 58.85M
Daiichi Sankyo 4568:JP Y 39030M 57M
Enanta Pharmaceuticals ENTA:US $ -33.85M 3.44M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Ironwood Pharmaceuticals IRWD:US $ 57.85M 1.25M
Novartis NOVN:VX 2.56B 671M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Tg Therapeutics TGTX:US $ -92.95M 7.82M
Xencor XNCR:US $ 26.47M 65.19M